Neratinib in patients with HER2-mutant, metastatic cervical cancer: findings from the phase 2 SUMMIT ‘basket’ trial

D’Souza, A; Roman, L.D.; Saura, C; Brana, I; Shapiro, G.I.; Passalacqua, R.; Piha-Paul, S.; Cutler, R.E.; Shahin, S; Eli, L.D.; Xu, F.; Dujka, M.; Lalani, A.S.; Bryce, R.; Meric-Bernstam, F.; Solit, D.B.; Hyman, D.M.

doi:10.1016/j.ygyno.2019.04.033

Record: found
Abstract: not found
Article: not found

Neratinib in patients with HER2-mutant, metastatic cervical cancer: findings from the phase 2 SUMMIT ‘basket’ trial

Author(s): A. D’Souza , L.D. Roman , C. Saura , I. Braña , G.I. Shapiro , R. Passalacqua , S. Piha-Paul , R.E. Cutler , S. Shahin , L.D. Eli , F. Xu , M. Dujka , A.S. Lalani , R. Bryce , F. Meric-Bernstam , D.B. Solit , D.M. Hyman

Publication date Created: June 2019

Publication date (Print): June 2019

Journal: Gynecologic Oncology

Publisher: Elsevier BV

Read this article at

ScienceOpenPublisher

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Title: Gynecologic Oncology

Abbreviated Title: Gynecologic Oncology

Publisher: Elsevier BV

ISSN (Print): 00908258

Publication date Created: June 2019

Publication date (Print): June 2019

Volume: 154

Page: 11

Article

DOI: 10.1016/j.ygyno.2019.04.033

SO-VID: c2ef67a7-f0d6-4aa0-a346-38ca14491599

License:

https://www.elsevier.com/tdm/userlicense/1.0/

History

Data availability:

Neratinib in patients with HER2-mutant, metastatic cervical cancer: findings from the phase 2 SUMMIT ‘basket’ trial

Read this article at

Related collections

Herbal Medicines Journal (Herb Med J)

Author and article information

Journal

Article

History

Comments

Comment on this article

Similar content 3,516